This week, the FDA filed a permanent injunction against two Minnesota companies that marketed and sold amino acid supplements as treatments for Parkinson’s, Alzheimer’s and other neurological disorders. To make matters worse, the companies also marketed their “amino-acid therapy” products as treatments for other problems, such as depression, attention-deficit hyperactivity disorder, fibromyalgia and obsessive compulsive [...]
